Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.Cancer|April 8, 2015
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trialDeborah W Bruner, Daniel Hunt, Jeff M Michalski, et al.European Urology Oncology|May 7, 2025
Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate CancerNoelia Sanmamed, Ian Dayes, Charles Catton, et al.JAMA Oncology|March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical TrialJeff M Michalski, Jennifer Moughan, James Purdy, et al.International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408Daniel J Krauss, Chen Hu, Jean-Paul Bahary, et al.Oncotarget|April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendrogliomaMatthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.The Journal of Sexual Medicine|May 27, 2017
External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate CancerRaisa S Pompe, Pierre I Karakiewicz, Emanuele Zaffuto, et al.European Urology|September 13, 2015
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08Justin C Voog, Rebecca Paulus, William U Shipley, et al.Urologic Oncology|July 7, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01Raymond H Mak, Daniel Hunt, Jason A Efstathiou, et al.International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic AstrocytomaJessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.Pageof 9